dr. jasgit sachdev on antibody-drug conjugate pf-06647020 in ovarian cancer
Published 7 years ago • 260 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
1:08
findings of a study with a novel antibody-drug conjugate in ovarian cancer
-
2:47
antibody drug conjugates for ovarian cancer
-
1:30
dr. english on an investigational antibody-drug conjugate in ovarian cancer
-
0:46
antibody-drug conjugates in gynecological cancers
-
1:06
dr. wong on antibody-drug conjugate research in multiple myeloma
-
1:53
baseline tumor size as a prognostic index in patients with cancer receiving targeted agents
-
29:20
jason s. carroll - understanding estrogen receptor transcription in breast cancer
-
2:51
lactobacillus & bifidobacterium - finding the right probiotic for you
-
1:11
jasgit sachdev, md, on new drugs for treating patients w/ triple negative breast cancer.
-
2:39
dr. diefenbach explains antibody drug conjugates
-
3:23
antibody-drug conjugates in the treatment of solid tumors
-
1:11
development of antibody-drug conjugate therapies in breast cancer
-
6:44
antibody-drug conjugates in treating tnbc
-
0:50
jasgit sachdev, md, on liquid biopsy as a promising technology for breast cancer treatment
-
6:17
antibody-drug conjugates in tnbc: sacituzumab govitecan
-
0:39
phase i/ii study of adapt-001 plus an ici for patients with immune refractory cancers
-
0:49
optimizing patient selection for antibody drug conjugates in breast cancer
-
0:44
adcs in early breast cancer
-
1:04
dr. isaacs discusses antibody drug conjugates in tnbc
-
7:09
understanding antibody drug conjugates
-
0:50
why mariajose chooses cst antibodies
-
1:14
prognostic value of beta-2 adrenergic receptor levels in her2 breast cancer